InsidersTradesSigma
Explore the detailed record of transactions filed by Fundaro Paolo, Director. Director active across 1 companies, notably Intercept Pharmaceuticals, INC.. Aggregated, 3 reports have been published. The latest transaction was filed on 25 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations
Paolo Fundaro is a Board Member at INTERCEPT PHARMACEUTICALS, INC. He contributes to the governance of the company by bringing his expertise and participating in strategic decisions within the board of directors.